Global Indemnity Group, LLC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Global Indemnity Group, LLC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $450.10M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $441.19M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $528.13M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $628.53M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $678.27M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $583.55M | Mar 15, 2023 |
| FY2021 | Dec 31, 2019 | $604.47M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $498.94M | Mar 12, 2021 |
| FY2019 | Dec 31, 2017 | $485.52M | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $534.51M | Mar 14, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.33M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $43.24M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $25.43M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | ($850.0K) | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $29.35M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | ($21.01M) | Mar 15, 2023 |
| FY2019 | Dec 31, 2019 | $29.03M | Mar 6, 2020 |
| FY2019 | Sep 30, 2019 | $6.72M | Mar 6, 2020 |
| FY2019 | Jun 30, 2019 | $14.66M | Mar 6, 2020 |
| FY2019 | Mar 31, 2019 | $19.60M | Mar 6, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.07M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $38.84M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $42.89M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $44.24M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $90.80M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $32.67M | Mar 15, 2023 |
| FY2021 | Dec 31, 2019 | $32.38M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $42.07M | Mar 12, 2021 |
| FY2019 | Dec 31, 2017 | ($18.91M) | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | ($19.21M) | Mar 14, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.72B | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.73B | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $1.73B | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $1.80B | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $2.01B | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $1.90B | Mar 15, 2023 |
| FY2021 | Dec 31, 2019 | $2.08B | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $1.96B | Mar 12, 2021 |
| FY2019 | Dec 31, 2017 | $2.00B | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $1.97B | Mar 14, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.01B | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.04B | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $1.08B | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $1.17B | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.31B | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $1.19B | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $1.35B | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $1.33B | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $1.28B | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $1.17B | Mar 9, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $706.59M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $689.15M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $648.75M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $626.23M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $706.62M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $718.32M | Mar 15, 2023 |
| FY2021 | Dec 31, 2019 | $726.81M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $629.06M | Mar 12, 2021 |
| FY2019 | Dec 31, 2017 | $718.39M | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $797.95M | Mar 14, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.82M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $4.82M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $4.82M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $4.82M | Mar 15, 2024 |
| FY2023 | Dec 31, 2021 | $5.40M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $6.52M | Mar 15, 2023 |
| FY2020 | Dec 31, 2019 | $6.52M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $6.52M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $6.52M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $6.52M | Mar 9, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $273.56M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $268.67M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $244.99M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $233.47M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $249.30M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $234.97M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $270.77M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $215.13M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $275.84M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $368.28M | Mar 9, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.54M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $17.01M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $38.04M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $38.85M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $78.28M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $67.36M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $44.27M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $99.50M | Mar 6, 2020 |
| FY2019 | Dec 31, 2017 | $74.41M | Mar 6, 2020 |
| FY2019 | Dec 31, 2016 | $75.11M | Mar 6, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | Mar 15, 2023 |
| FY2022 | Dec 31, 2021 | $126.43M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $126.29M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $296.64M | Mar 12, 2021 |
| FY2019 | Dec 31, 2018 | $288.57M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $294.71M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $163.14M | Mar 9, 2018 |
| FY2016 | Dec 31, 2015 | $172.03M | Mar 10, 2017 |
| FY2015 | Dec 31, 2014 | $174.67M | Mar 14, 2016 |
| FY2013 | Dec 31, 2012 | $84.93M | Mar 14, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Mar 15, 2023 |
| FY2021 | Dec 31, 2019 | 4 | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | (4) | Mar 12, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | 2 | Mar 14, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Mar 15, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 12, 2021 |
| FY2020 | Sep 30, 2020 | (1) | Mar 12, 2021 |
| FY2020 | Jun 30, 2020 | 2 | Mar 12, 2021 |
| FY2020 | Mar 31, 2020 | (3) | Mar 12, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Mar 12, 2021 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.00M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $19.39M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $14.25M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $14.37M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $14.43M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $14.25M | Mar 15, 2023 |
| FY2021 | Dec 31, 2019 | $14.22M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $14.03M | Mar 12, 2021 |